Consumer Defensive -
Household & Personal Products - NYSE - US
$ 47.98
1.1 %
$ 10.3 B
Market Cap
70.56
P/E
1. INTRINSIC VALUE
Balance Sheet
Hims & Hers Health, Inc.
| Current Assets | 396 M |
| Cash & Short-Term Investments | 300 M |
| Receivables | 6.08 M |
| Other Current Assets | 89.5 M |
| Non-Current Assets | 312 M |
| Long-Term Investments | 856 K |
| PP&E | 93 M |
| Other Non-Current Assets | 218 M |
| Current Liabilities | 221 M |
| Accounts Payable | 91.2 M |
| Short-Term Debt | 3.78 M |
| Other Current Liabilities | 126 M |
| Non-Current Liabilities | 9.46 M |
| Long-Term Debt | 9.46 M |
| Other Non-Current Liabilities | 0 |
EFFICIENCY
Earnings Waterfall
Hims & Hers Health, Inc.
| Revenue | 1.48 B |
| Cost Of Revenue | 303 M |
| Gross Profit | 1.17 B |
| Operating Expenses | 1.11 B |
| Operating Income | 61.9 M |
| Other Expenses | -64.1 M |
| Net Income | 126 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Hims & Hers Health, Inc.
| Net Income | 126 M |
| Depreciation & Amortization | 17.1 M |
| Capital Expenditures | -41.7 M |
| Stock-Based Compensation | 92.3 M |
| Change in Working Capital | 78.6 M |
| Others | 75.2 M |
| Free Cash Flow | 209 M |
Wall Street Analysts Price Targets
Hims & Hers Health, Inc.
Wall Street analysts predict an average 1-year price target for HIMS of $31.5 , with forecasts ranging from
a
low of
$18 to a high of $68 .
HIMS Lowest Price Target
Wall Street Target
18 USD
-62.48%
HIMS Average Price Target
Wall Street Target
31.5 USD
-34.28%
HIMS Highest Price Target
Wall Street Target
68 USD
41.73%
4. DIVIDEND
ANALYSIS
HIMS does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Hims & Hers Health, Inc.
Sold
0-3 MONTHS
38.8 M USD 6
3-6 MONTHS
43 M USD 8
6-9 MONTHS
46.7 M USD 8
9-12 MONTHS
22.6 M USD 7
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
132 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
globenewswire.com
- 1 week ago
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hims To Contact Him Directly To Discuss Their Options
globenewswire.com
- 1 week ago
HIMS SHAREHOLDER ALERT: Suffer Losses on Hims & Hers Health, Inc.? Contact BFA Law by August 25 Securities Fraud Class Action Deadline (NYSE:HIMS)
NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Hims & Hers, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/hims-hers-health-inc-class-action.
globenewswire.com
- 1 week ago
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS
NEW YORK and NEW ORLEANS , July 4, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS), if they purchased the Company's securities between April 29, 2025 and June 23, 2025, inclusive (the "Class Period").
prnewswire.com
- 1 week ago
HIMS SHAREHOLDERS: The Hims & Hers Health, Inc. August 25 Class Action Deadline is Approaching -- Contact BFA Law if You Suffered Losses (NYSE:HIMS)
NEW YORK, July 04, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Hims & Hers, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/hims-hers-health-inc-class-action.
globenewswire.com
- 1 week ago
INVESTOR DEADLINE: Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO , July 4, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, all dates inclusive (the "Class Period"), have until August 25, 2025 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v.
prnewswire.com
- 1 week ago
Robbins LLP Urges HIMS Stockholders with Large Losses to Contact the Firm for Information About the Class Action Pending Against Hims & Hers Health, Inc.
SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 22, 2025. Hims operates a telehealth platform that connects consumers to licensed healthcare professionals.
globenewswire.com
- 1 week ago
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Hims & Hers Health, Inc. (HIMS) Shareholders
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit.
globenewswire.com
- 1 week ago
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS) and certain of its officers.
globenewswire.com
- 1 week ago
Hims & Hers Enhances Healthcare Through AI-Driven Personalization
HIMS taps AI and $870 million in funding to deliver smarter, more personalized healthcare through tech-driven innovation.
zacks.com
- 1 week ago
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
BENSALEM, Pa. , July 3, 2025 /PRNewswire/ -- The Law Offices of Howard G.
prnewswire.com
- 1 week ago
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - HIMS
SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”), have until August 25, 2025 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v. Hims & Hers Health, Inc., No. 25-cv-05315 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers as well as certain of Hims & Hers' top executives with violations of the Securities Exchange Act of 1934. A subsequently filed complaint is captioned Yaghsizian v. Hims & Hers Health, Inc., No. 25-cv-05321 (N.D. Cal.).
globenewswire.com
- 1 week ago
8. Profile
Summary
Hims & Hers Health, Inc. HIMS
COUNTRY
US
INDUSTRY
Household & Personal Products
MARKET CAP
$ 10.3 B
Dividend Yield
0.00%
Description
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
Contact
2269 Chestnut Street, San Francisco, CA, 94123
https://www.forhims.com
IPO
Date
Sept. 13, 2019
Employees
1637
Officers
Mr. Andrew Dudum
Co-Founder, Chairman & Chief Executive Officer
Ms. Soleil Teubner Boughton J.D.
Chief Legal Officer & Corporate Secretary
Mr. Nader Kabbani
Chief Operations Officer
Ms. Irene A. Becklund
Senior Vice President, Controller & Principal Accounting Officer
Mr. Mohamed ElShenawy
Chief Technology Officer
Dr. Patrick Carroll M.D.
Chief Medical Officer & Director
Ms. Khobi Brooklyn
Chief Communications Officer
Mr. Oluyemi Okupe
Chief Financial Officer
Mr. Mike Chi
Chief Commercial Officer
Dr. Peter Stahl M.D.
Senior Vice President of Men's Reproductive & Sexual Health